We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Erratum to: SD1000: High Sustained Viral Response Rate in 1361 Patients With Hepatitis C Genotypes 1, 2, 3, and 4 Using a Low-cost Fixed-dose Combination Tablet of Generic Sofosbuvir and Daclatasvir: A Multicenter Phase III Clinical Trial.
- Authors
Merat, Shahin; Sharifi, Amir-Houshang; Poustchi, Hossein; Hajiani, Eskandar; Gharavi, Abdolsamad; Karimi, Jalal; Mansour-Ghanaei, Fariborz; Fattahi, Mohammad-Reza; Ahmadi, Lida; Somi, Mohammad-Hossein; Kalantari, Hamid; Ghadir, Mohammad-Reza; Sheikhesmaeili, Farshad; Baniasadi, Nadieh; Sohrabi, Masoudreza; Moosavy, Seyedhamid; Ziaee, Masood; Zahedi, Mohammad-Javad; Mokhtare, Marjan; Sali, Shahnaz
- Abstract
A correction is presented to the article "SD1000: High Sustained Viral Response Rate in 1361 Patients With Hepatitis C Genotypes 1, 2, 3, and 4 Using a Low-cost Fixed-dose Combination Tablet of Generic Sofosbuvir and Daclatasvir: A Multicenter Phase III Clinical Trial" which appeared in the previous issue.
- Subjects
DRUG tablets; COMBINATION drug therapy; HEPATITIS C; ANTIVIRAL agents; NUCLEOTIDES; IMIDAZOLES; GENOTYPES; GENERIC drugs; DRUGS; PATIENT compliance; THERAPEUTICS
- Publication
Clinical Infectious Diseases, 2021, Vol 73, Issue 1, p172
- ISSN
1058-4838
- Publication type
Correction Notice
- DOI
10.1093/cid/ciaa1768